Gene Therapy for Hereditary Hearing Loss Moves Toward Younger Ages: SKY-GJB2 Recommended for Children Under Two
Safety data from four older children have led to a review recommendation to expand the SONIX trial to younger ages. Whether earlier intervention can improve hearing and language development awaits human efficacy data.